Latest Lead News

Anteris Technologies Global Corp. has raised A$38.5 million in a private placement to accelerate the global commercialization and pivotal clinical trial of its innovative DurAVR® transcatheter aortic valve replacement device.

Neurotech International has initiated an Authorised Prescriber program for its lead therapy NTI164, expanding access for children with neurodevelopmental disorders in Australia. The company also secured a Rare Pediatric Disease Designation from the US FDA for NTI164 in Rett Syndrome, marking a key regulatory milestone.

Motio Limited has raised $1.73 million through a placement to accelerate its digital display network expansion and repay debt early, aiming to reach profitability sooner.

Caspin Resources has commenced Phase 1 drilling at its Weethalle Gold Project in NSW, aiming to test a newly identified 2,000m long geophysical anomaly linked to historic high-grade gold mineralisation. The project’s geological setting mirrors that of the prolific Hemi deposit, raising exploration hopes.

Anteris Technologies has enrolled the first patients in its pivotal PARADIGM Trial, testing the DurAVR Transcatheter Heart Valve against leading competitors in a global study.

Podium Minerals has successfully raised A$7 million through an oversubscribed entitlement offer, strengthening its cash position to advance the Parks Reef PGM Project. The capital raise follows a prior A$5 million placement, bringing total equity raised to A$12 million.

Lincoln Minerals has identified promising new drill targets at its Minbrie Copper-Base Metals Project in South Australia and secured $2.25 million in funding to advance exploration activities.

DigitalX Limited has enhanced its treasury strategy by investing nearly A$5 million into a market-neutral fund while increasing its Bitcoin holdings to over 500 BTC, aiming to balance accumulation with steady income generation.

Atomos Limited has posted its first positive EBITDA quarter since late 2022, driven by strong sales of its flagship Ninja and Shinobi products. The company’s operational overhaul and strategic product launches set the stage for continued growth into Q2 FY26.

Optiscan Imaging Ltd secured $17.75 million in a fully underwritten equity raise, fueling clinical studies and regulatory preparations for its innovative medical imaging devices. The company also reported progress in international trials and strengthened its cash position to nearly $20 million.

Element 25 Limited has raised AU$10 million to advance its Butcherbird Expansion Project in Western Australia, aiming to increase manganese production and support its innovative battery materials refinery in the US.

Syrah Resources resumed graphite production at its Balama mine and advanced its Vidalia anode material facility amid supportive US trade tariffs and tax credits, positioning itself strongly in the growing EV battery market.